| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Genentech/Roche |
| Recipient: Your Institution |
| Company: Lilly |
| Recipient: Your Institution |
| Company: Daiichi Sankyo |
| Recipient: Your Institution |
| Company: Mersana |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Ellipses Pharma |
| Recipient: Your Institution |
| Company: Olema Pharmaceuticals |
| Recipient: Your Institution |
| Company: Stemline Therapeutics |
| Recipient: Your Institution |
| Company: Tubulis |
| Recipient: Your Institution |
| Company: Verascity Science |
| Recipient: Your Institution |
| Company: Theratechnologies |
| Recipient: Your Institution |
| Company: Accutar Biotechnology |
| Recipient: Your Institution |
| Company: Entos |
| Recipient: Your Institution |
| Company: Fosun Pharma |
| Recipient: Your Institution |
| Company: Gilead Sciences |
| Recipient: Your Institution |
| Company: Jazz Pharmaceuticals |
| Recipient: Your Institution |
| Company: Medical Pharma Services |
| Recipient: Your Institution |
| Company: Zentalis Pharmaceuticals |
| Recipient: Your Institution |
| Company: Jefferies |
| Recipient: Your Institution |
| Company: Tempus Labs |
| Recipient: Your Institution |
| Company: Arvinas |
| Recipient: Your Institution |
| Company: Circle Pharma |
| Recipient: Your Institution |
| Company: Janssen |
| Recipient: Your Institution |
| Company: Johnson and Johnson |
| Recipient: Your Institution |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Hutchison MediPharma |
| Recipient: Your Institution |
| Company: OncoMed |
| Recipient: Your Institution |
| Company: MedImmune |
| Recipient: Your Institution |
| Company: Stem CentRx |
| Recipient: Your Institution |
| Company: Genentech/Roche |
| Recipient: Your Institution |
| Company: Curis |
| Recipient: Your Institution |
| Company: Verastem |
| Recipient: Your Institution |
| Company: Zymeworks |
| Recipient: Your Institution |
| Company: Syndax |
| Recipient: Your Institution |
| Company: Lycera |
| Recipient: Your Institution |
| Company: Rgenix |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Mersana |
| Recipient: Your Institution |
| Company: Millennium |
| Recipient: Your Institution |
| Company: TapImmune Inc. |
| Recipient: Your Institution |
| Company: Lilly |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Tesaro |
| Recipient: Your Institution |
| Company: Boehringer Ingelheim |
| Recipient: Your Institution |
| Company: H3 Biomedicine |
| Recipient: Your Institution |
| Company: Radius Health |
| Recipient: Your Institution |
| Company: Acerta Pharma |
| Recipient: Your Institution |
| Company: Macrogenics |
| Recipient: Your Institution |
| Company: Abbvie |
| Recipient: Your Institution |
| Company: Immunomedics |
| Recipient: Your Institution |
| Company: Fujifilm |
| Recipient: Your Institution |
| Company: eFFECTOR Therapeutics |
| Recipient: Your Institution |
| Company: Merus |
| Recipient: Your Institution |
| Company: Nucana |
| Recipient: Your Institution |
| Company: Regeneron |
| Recipient: Your Institution |
| Company: Leap Therapeutics |
| Recipient: Your Institution |
| Company: Taiho Pharmaceutical |
| Recipient: Your Institution |
| Company: EMD Serono |
| Recipient: Your Institution |
| Company: Daiichi Sankyo |
| Recipient: Your Institution |
| Company: ArQule |
| Recipient: Your Institution |
| Company: Syros Pharmaceuticals |
| Recipient: Your Institution |
| Company: Clovis Oncology |
| Recipient: Your Institution |
| Company: CytomX Therapeutics |
| Recipient: Your Institution |
| Company: InventisBio |
| Recipient: Your Institution |
| Company: Deciphera |
| Recipient: Your Institution |
| Company: Sermonix Pharmaceuticals |
| Recipient: Your Institution |
| Company: Sutro |
| Recipient: Your Institution |
| Company: Zenith Epigenetics |
| Recipient: Your Institution |
| Company: Arvinas |
| Recipient: Your Institution |
| Company: Harpoon |
| Recipient: Your Institution |
| Company: Black Diamond |
| Recipient: Your Institution |
| Company: Orinove |
| Recipient: Your Institution |
| Company: Molecular Templates |
| Recipient: Your Institution |
| Company: Seattle Genetics |
| Recipient: Your Institution |
| Company: Compugen |
| Recipient: Your Institution |
| Company: G1 Therapeutics |
| Recipient: Your Institution |
| Company: Karyopharm Therapeutics |
| Recipient: Your Institution |
| Company: Dana Farber Cancer Hospital |
| Recipient: Your Institution |
| Company: Shattuck Labs |
| Recipient: Your Institution |
| Company: PharmaMar |
| Recipient: Your Institution |
| Company: Olema Pharmaceuticals |
| Recipient: Your Institution |
| Company: Immunogen |
| Recipient: Your Institution |
| Company: Plexxikon |
| Recipient: Your Institution |
| Company: Amgen |
| Recipient: Your Institution |
| Company: Akesobio Australia |
| Recipient: Your Institution |
| Company: ADC Therapeutics |
| Recipient: Your Institution |
| Company: AtlasMedx |
| Recipient: Your Institution |
| Company: Aravive |
| Recipient: Your Institution |
| Company: Ellipses Pharma |
| Recipient: Your Institution |
| Company: Incyte |
| Recipient: Your Institution |
| Company: MabSpace Biosciences |
| Recipient: Your Institution |
| Company: ORIC Pharmaceuticals |
| Recipient: Your Institution |
| Company: Pieris Pharmaceuticals |
| Recipient: Your Institution |
| Company: Pionyr |
| Recipient: Your Institution |
| Company: Repertoire Immune Medicines |
| Recipient: Your Institution |
| Company: Treadwell Therapeutics |
| Recipient: Your Institution |
| Company: Jacobio |
| Recipient: Your Institution |
| Company: Accutar Biotech |
| Recipient: Your Institution |
| Company: Artios |
| Recipient: Your Institution |
| Company: Bliss Biopharmaceutical |
| Recipient: Your Institution |
| Company: Cascadian Therapeutics |
| Recipient: Your Institution |
| Company: Dantari |
| Recipient: Your Institution |
| Company: Duality Biologics |
| Recipient: Your Institution |
| Company: Elucida Oncology |
| Recipient: Your Institution |
| Company: Infinity Pharmaceuticals |
| Recipient: Your Institution |
| Company: Relay Therapeutics |
| Recipient: Your Institution |
| Company: Tolmar |
| Recipient: Your Institution |
| Company: Torque |
| Recipient: Your Institution |
| Company: BeiGene |
| Recipient: Your Institution |
| Company: Context Therapeutics |
| Recipient: Your Institution |
| Company: K-Group Beta |
| Recipient: Your Institution |
| Company: Kind Pharmaceuticals |
| Recipient: Your Institution |
| Company: Loxo Oncology |
| Recipient: Your Institution |
| Company: Oncothyreon |
| Recipient: Your Institution |
| Company: Orum Therapeutics |
| Recipient: Your Institution |
| Company: Prelude Therapeutics |
| Recipient: Your Institution |
| Company: Profound Bio |
| Recipient: Your Institution |
| Company: Cullinan Oncology |
| Recipient: Your Institution |
| Company: Bristol-Myers Squib |
| Recipient: Your Institution |
| Company: Eisai |
| Recipient: Your Institution |
| Company: Fochon Pharmaceuticals |
| Recipient: Your Institution |
| Company: Gilead Sciences |
| Recipient: Your Institution |
| Company: Inspirna |
| Recipient: Your Institution |
| Company: Myriad Genetics |
| Recipient: Your Institution |
| Company: Silverback Therapeutics |
| Recipient: Your Institution |
| Company: Stemline Therapeutics |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|